Drug Action
Deflazacort is derived from prednisolone; it has predominantly glucocorticoid activity.
Source page 733
Individual generic drug information
Extracted information for Deflazacort only.
Deflazacort is derived from prednisolone; it has predominantly glucocorticoid activity.
Source page 733
Suppression of inflammatory and allergic disorders ▶BY MOUTH ▶Adult: Maintenance 3–18 mg daily Suppression of inflammatory and allergic disorders (acute disorders) ▶BY MOUTH continued → ▶Adult: Initially up to 120 mg daily Inflammatory and allergic disorders ▶BY MOUTH ▶Child 1 month–11 years: 0.25–1.5 mg/kg once daily or on alternate days; increased if necessary up to 2.4 mg/kg daily (max. per dose 120 mg), in emergency situations ▶Child 12–17 years: 3–18 mg once daily or on alternate days; increased if necessary up to 2.4 mg/kg daily (max. per dose 120 mg), in emergency situations
Source pages 733, 734
Extracted information for Deflazacort only.
→Appendix 1: corticosteroids Endocrine system
Source page 734
▶Uncommon Oedema
Source page 734
Dose adjustments Manufacturer advises adjust to the minimum effective dose.
Source page 734
Extracted information for Deflazacort only.
There can be variation in the licensing of different medicines containing the same drug. Forms available from special-order manufacturers include: tablet Tablet CAUTIONARY AND ADVISORY LABELS 5, 10 ▶Calcort (Sanofi) Deflazacort 6 mg Calcort 6mg tablets | 60 tablet P £15.82 DT = £15.82 eiiii F 709
Source page 734
Extracted information for Deflazacort only.
Patient counselling is advised for deflazacort tablets (steroid card).
Source page 734
Filter the extracted dose blocks for this individual drug.
First line only; read the complete Indications and dose section above.
Maintenance 3–18 mg daily
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 733
First line only; read the complete Indications and dose section above.
Initially up to 120 mg daily
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 733